EpiBone is a bone reconstruction company that advances skeletal reconstruction through 3D design and living cells.
EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
EpiBone’s technology works in a three-step process:
- Imaging and stem cell extraction
- Graft and bioreactor design
- Bone growth
Product:
EpiBone Bioreactor
This bioreactor is the product of 20 years’ research and experience with orthopaedic tissue engineering. Its function is to mimic the finely calibrated conditions of the human body that enable bone to grow. EpiBone’s technology uses a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a bone graft in the patented Bioreactor with the precise anatomical fit to the defect being treated. Bones that grow in the patented EpiBone bioreactor are ready in just three weeks, and continue to be remodelled and vascularized once they are transplanted into a patient.